Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

AIM WINNERS & LOSERS: Origo to delist; Northcoders revenue doubles

26th Apr 2022 10:42

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

----------

AIM - WINNERS

----------

Northcoders Group PLC, up 26% at 322.50 pence, 12-month range 175.00p-390.00p. Manchester-based Northcoders says its revenue more than doubled in 2021, a year in which the provider of training programmes for software coding expanded its footprint. Revenue surges to GBP3.0 million from GBP1.3 million. Its pretax loss narrowed to GBP523,588 from GBP1.2 million. In 2021, it signed a lease for a "core hub" in Leeds, to go along with its Manchester campus.

----------

Chariot Ltd, up 8.7% at 21.42 pence, 12-month range 0.050p-22.40p. The Africa-focused transitional energy company names Societe Generale SA as financial advisor to help shore up debt funding options for the Anchois gas development in offshore Morocco.

----------

AIM - LOSERS

----------

Origo Partners PLC, down 52% at 0.050p, 12-month range 0.00080p-0.081p. The investment company says its shares will be suspended from trading on Thursday, before being cancelled in late-May. Origo says that since Arden Partners PLC is being acquired by Ince Group PLC, it is no longer able to serve as its nominated advisor. It means that should Origo wish to continue trading on AIM, it must find a new nomad. Origo says it has fulfilled announced objectives, including returning proceeds to shareholders, so appointing a new nomad is not in is best interests.

----------

Novacyt SA, down 14% at 167.61p, 12-month range 1.31p-173.95p. The Surrey-based biotechnology company's dispute with the UK Department of Health & Social Care continues. On Monday, the DHSC issued a GBP134.6 million claim against Novacyt in relation to a contract for the provision of Covid-19 testing kits, initially announced back in September 2020. "The company continues to believe it has strong grounds to defend the claim and assert its contractual rights, including in relation to recovering outstanding sums due from the DHSC," Novacyt says on Tuesday.

----------

By Eric Cunha; [email protected]

Copyright 2022 Alliance News Limited. All Rights Reserved.

FTSE 100 Latest
Value8,209.61
Change37.46